Management team

Our staff is our biggest asset. Their dedication, level of education and average over 17 years of industry experience determine your project success.

With our services we optimally position our customers to maneuver in the rapidly changing biopharmaceutical markets. With accelerated timelines, early completion of the preclinical phases and robust, scalable processes we enable our customers to meet the needs of those that suffer from diseases worldwide.

Dr. Christopher Yallop

Chief Operations and Scientific Officer

Dr. Menzo Havenga

President & Chief Executive Officer

Ron van Eijsden

Global Head of BD

Cedric Borgne

Head of Operations

Claire Harrison

General Counsel